Deprescribing: An umbrella review by Japelj Nuša, Horvat Nejc, Knez Lea, Kos Mitja

“…This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. …”
Get full text

Deprescribing proton pump inhibitors by Kim Jun Kevin Teh, Hai Kiat Troy Puar, Choon How How, Teck Kiang Malcolm Tan

Get full text

Proton pump inhibitor leaflets: Is there information on deprescribing? by Marcus Vinícius Lopes Campos, Farah Maria Drumond Chequer, Luanna Gabriella Resende da Silva, André Oliveira Baldoni

“…The variables collected in each leaflet were the existence: a) about deprescribing; b) of guidance on the deprescription process; c) maximum recommended time for use; and d) risk of prolonged use. …”
Get full text

Development of a Japanese version of the patient perceptions of deprescribing – Short form by Mio Kushibuchi, Kenya Ie, Masaki Takahashi, Amy M. Linsky, Steven M. Albert

Subjects: “…deprescribing…”
Get full text

Deprescribing attitudes and predictors among older adults attending geriatric clinics in Kuwait. by Hesah Alshammari, Eman Al-Saeed, Zamzam Ahmed, Zoe Aslanpour

“…Deprescribing is defined as the reduction of medications to improve patient care. …”
Get full text

Exploring the need for a clinical decision support system for deprescribing - A qualitative interview study by Aryoutha Asmar Talani, Tora Hammar, Ylva Böttiger

Subjects: Get full text

Enablers and barriers to community pharmacists' readiness to implement deprescribing of inappropriate medications for older adults in Qatar. by Marwa Elshazly, Sondus Jawad, Ayesha Ahmed, Hager ElGeed, Kazeem Babatunde Yusuff

“…There is paucity of studies focused on the enablers and barriers to community pharmacists' readiness to deprescribe inappropriate medications for older adults in developing settings. …”
Get full text

Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week) by V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, A. A. Sheptulin, V. I. Simanenkov, T. L. Lapina, I. B. Khlynov, N. N. Dekhnich, O. D. Lopina, O. P. Alekseeva, N. V. Korochanskaya, M. F. Osipenko, P. V. Pavlov, S. S. Pirogov, G. N. Tarasova, Yu. P. Uspenskiy, D. N. Andreev, D. E. Rumyantseva

Subjects: Get full text

Instruments for assessing healthcare professionals’ knowledge, attitudes and practices regarding deprescribing: a scoping review protocol by Luciane Cruz Lopes, Jardel Corrêa de Oliveira, Luis Phillipe Nagem Lopes, Mariana Del Grossi Moura, Ana Carolina Figueiredo Modesto, Laís Lessa Neiva Pantuzza

“…Objective To map instruments for assessing healthcare professionals’ knowledge, attitudes and practices regarding deprescribing.Introduction Deprescribing is essential for improving patient outcomes by managing polypharmacy, reducing fall risks and decreasing medication costs. …”
Get full text

Pharmacist interventions for older adults with polypharmacy in an ambulatory geriatric clinic by Antonietta Paneccasio, Anna Bondar, Emily Fargo, Marcie Parker, Ardeshir Hashmi, Kenneth Koncilja, Gina Elder

Subjects: Get full text

Move to improve - Prescribing physical activity and deprescribing paracetamol for low back pain: Protocol for a hybrid type III feasibility study by David Roberts, Paulo H Ferreira, Josielli Comachio, Paula R Beckenkamp, Thomas Patterson, Mark Halliday, Emma Kwan-Yee Ho

Get full text

Challenges and barriers to physician decision-making for prescribing and deprescribing among patients with multimorbidity in eastern China’s primary care settings: a qualitative study by Ming Yan, Zhijie Xu, Andrew Farmer, Yu Xia, Mi Yao, Lingyan Wu, Xinmei Zhou, Liyan Han

“…We aimed to investigate the experiences and perceptions of primary care physicians (PCPs) regarding their decision-making processes in prescribing and deprescribing medications for patients with multimorbidity, and identify the challenges and barriers they face.Design From 5 October 2023 to 27 January 2024, this qualitative study was conducted through semi-structured interviews that encouraged in-depth exploration of the participants’ experiences and perspectives. …”
Get full text

DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care by Stefan Neuner-Jehle, Katharina Tabea Jungo, Sven Streit, Sven Trelle, Nicolas Rodondi, Carole Elodie Aubert, Kristie Rebecca Weir, Enriqueta Vallejo-Yagüe, Samantha Chan, Marie Roumet, Pascal Juillerat, Sofia Carolina Zambrano Ramos, Jennifer Inauen, Angela Edith Schulthess-Lisibach, Renata Vidonscky Lüthold, Clémentine Tombez, Martina Zangger, Flurina Jenal, Yvonne Mattmann, Christof Bieri, Michaela Barbier

“…Nevertheless, PPIs are often overused leading to potential adverse effects and unnecessary healthcare costs. Deprescribing strategies have emerged to safely reduce or substitute inappropriate PPIs and optimise patient care in an evidence-based manner. …”
Get full text

Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project by Paar Elizabeta, De Lai Eleonora, Držaić Margita, Kummer Ingrid, Bužančić Iva, Hadžiabdić Maja Ortner, Brkic Jovana, Fialová Daniela

Subjects: Get full text

Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approv... by Ellie Santer, Julie H Hedayioglu, Vanessa J Short, Sabina Hulbert, Emma L Veale, Melanie Rees-Roberts, Johanna Theron

Subjects: Get full text

Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole by O. D. Lopina, B. K. Nurgalieva, T. L. Lapina

Subjects: “…proton pump inhibitor deprescribing…”
Get full text

Antipsychotic prescribing practices and patient, family member and healthcare professional perceptions of antipsychotic prescribing in acute care settings: a scoping review protoco... by Zahinoor Ismail, Daniel Niven, Kirsten Fiest, Lisa Burry, Karla D Krewulak, Natalia Jaworska, Stephana Julia Moss, Zara Stelfox

“…The results of this scoping review will inform integrated knowledge translation initiatives aimed at in-hospital antipsychotic medication deprescribing.…”
Get full text

Minimising harms of tight glycaemic control in older patients with type 2 diabetes by Wade Thompson

“…This Therapeutic Letter evaluates the risks of tight glycaemic control in older adults with T2DM, focusing on deprescribing diabetes medications in those over 65, especially those with multimorbidity and polypharmacy. …”
Get full text

Barriers and enablers to opioid deprescription: A qualitative study. by Rebecca Lawrence, Everett Versteeg, Andrea Pike, Holly Etchegary, Amanda Hall

“…Barriers include a lack of knowledge and skills related to deprescribing, discomfort initiating deprescription, patient pressure to continue prescribing opioids, and a lack of foundational support required to deprescribe. …”
Get full text

Operation Polypharmacy: a pharmacist-led ambulatory care clinic design and evaluation for older patients by Nicha Tantipinichwong, Michelle S. Keller

“…Patients were on 17.3 (range: 7–33) medications at-visit and 15.9 (range: 4–30) medications post-visit, with an average of 1.4 medications deprescribed per visit. In patients with many medications (range: 17–33 medications) at the polypharmacy consult visit, 2.6 medications were deprescribed post-visit. …”
Get full text